Analysts Viewpoint
Analysts review SELLAS Life Sciences Group Inc’s rating
SELLAS Life Sciences Group Inc’s recent filing unveils that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported
Menu
SELLAS Life Sciences Group Inc’s recent filing unveils that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
SELLAS Life Sciences Group Inc’s filing revealed that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported $14800.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
SELLAS Life Sciences Group Inc’s recently made public that its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, SELLAS Life Sciences Group Inc revealed its Director VAN NOSTRAND ROBERT L acquired Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its